(Q47400057)

English

The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial

scientific article published in January 1993

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

1 reference

based on heuristic

inferred from title

author name string

J F Bishop

1

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

J G Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

P N Jeal

3

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

R Murray

4

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

R M Drummond

5

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

P Pitt

6

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

I N Olver

7

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

A K Bhowal

8

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

29A

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

6

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

814-818

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

Tamoxifen (antiestrogen) therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihormone treatment of stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pituitary Gonadotropin Inhibitory Activity of Danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Danazol—A Steroid with a Unique Combination of Actions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Danazol therapy in hormone-sensitive mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Megestrol acetate: clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980415-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(05)80415-0

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/8484970

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47400057&oldid=2214600526"